12/5
08:09 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target lowered by analysts at HC Wainwright from $21.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target lowered by analysts at HC Wainwright from $21.00 to $7.00. They now have a "buy" rating on the stock.
12/4
08:00 am
neup
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
Low
Report
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
12/2
08:06 pm
neup
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders [Yahoo! Finance]
Medium
Report
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders [Yahoo! Finance]
12/1
08:10 am
neup
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions [Yahoo! Finance]
Low
Report
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions [Yahoo! Finance]
12/1
08:00 am
neup
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Low
Report
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
11/24
08:00 am
neup
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
Medium
Report
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
11/23
02:11 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
11/23
02:11 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
11/15
01:42 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at
Wall St
Medium
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at
Wall St
11/11
07:26 am
neup
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value [Yahoo! Finance]
Medium
Report
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value [Yahoo! Finance]
11/11
07:00 am
neup
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
Low
Report
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
11/1
01:05 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
10/27
04:29 pm
neup
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
Low
Report
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
10/8
12:30 pm
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
9/29
05:32 pm
neup
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates [Yahoo! Finance]
9/29
04:54 pm
neup
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Low
Report
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
9/11
10:42 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target raised by analysts at Maxim Group from $18.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target raised by analysts at Maxim Group from $18.00 to $35.00. They now have a "buy" rating on the stock.